News and Updates

Skye Bioscience acquires Redx Pharma, exiting the obesity drug market to focus exclusively on developing novel treatments for fibrosis.

Citius Pharmaceuticals reports growing revenue for CTCL treatment LYMPHIR, with new clinical plans to explore synergistic CAR-T combination therapies.

LSD succeeds in two Phase 3 clinical trials, showing promise for mental health. Explore the complex regulatory path ahead for psychedelic-assisted therapy.

Discover how emerging biologic therapies like PRP and stem cells are transforming knee osteoarthritis treatment and prioritizing long-term joint health.

Considering a clinical trial? Learn the essential eligibility, logistical, and safety factors to navigate the research process successfully.

AI is surging in clinical trials, but does the evidence match the hype? Learn why trial operators must prioritize validation to avoid dangerous bias.

New research reveals an enzyme-targeting drug that prevents lung cancer by curbing inflammation. Learn how this breakthrough could transform prevention.

The FDA has finalized new guidance for formal meetings with drug sponsors. Discover how these updated protocols will impact PDUFA drug development.

Can climbing stairs improve heart health? New research reveals that taking just six flights of stairs daily significantly lowers your cardiovascular risk.

The FDA has approved a breakthrough multiple myeloma therapy. Discover how this new targeted treatment could improve survival rates for refractory patients.